* Overall weighted average primary patency is based on data from 15 peer-reviewed publications meeting pre-determined inclusion criteria.
Study size (N) reflects the initial cohert size of the study.
Inclusion criteria for above-knee fem-pop GORE® PROPATEN® Vascular Graft data used in this analysis:
- Peer-reviewed clinical journal publications in English language
- Non-overlapping patient populations
- AK bypass primary patency reported for at least 12 months of follow-up
- N = 50 or more AK fem-pop bypass in the GORE® PROPATEN® Vascular Graft treatment arm
- Data of analysis on file